Reckitt Benckiser Group plc
RBGPF
Market Cap$39.96B
Close$
Earnings Call Q7 2023
February 29, 2024 - AI Summary
Reckitt reported full-year net revenue growth of 3.5% on a like-for-like basis, exceeding expectations.
Q4 performance was unsatisfactory due to weak OTC sales driven by the phasing and shape of the cold and flu season, a voluntary product recall in the Nutrition business, and an understatement of trade spend in two Middle Eastern markets.
The company has zero tolerance for inappropriate behavior and has taken disciplinary action against employees involved in the trade spend issue.
Exclusive for Stockcircle Pro members
Sign up
$115.97
105.3% upside
Current Fair Value
105.3% upsideUndervalued by 105.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $39.96 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $1.925 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 0.0 |
| Outstanding Shares | 705,553,369 |
| Avg 30 Day Volume | 12,565 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About Reckitt Benckiser Group Plc
CEO: Laxman Narasimhan Reckitt Benckiser Group Plc engages in the manufacture and trade of health, hygiene and home products. It operates through Health and Hygiene Home segments. The Health segment focuses on infant and child nutrition; health relief; health ...